Skip to main content
TRELLUS HEALTH PLC logo

TRELLUS HEALTH PLC — Investor Relations & Filings

Ticker · TRLS ISIN · GB00BNNFM402 LEI · 2138002FHWJSR8YKP295 IL Human health and social work activities
Open in API
Filings indexed 120 across all filing types
Latest filing 2023-02-17 Regulatory Filings
Country GB United Kingdom
Listing IL TRLS

About TRELLUS HEALTH PLC

https://trellushealth.com/

Trellus Health PLC is a digital health company that provides solutions for managing complex chronic conditions by addressing the intersection of physical and mental health. The company's core offering is Trellus Elevate®, a clinically proven, resilience-focused program. This platform combines human-led, one-on-one virtual support from a specialized team of coaches, dietitians, and educators with personalized digital tools for symptom management and progress tracking. The program aims to empower individuals to proactively manage their health, improve adherence to treatment plans, and enhance their quality of life. Trellus Health's solutions are designed to reduce healthcare costs for its partners, which include health plans, employers, providers, health systems, and pharmaceutical companies.

Recent filings

Filing Released Lang Actions
Launch of D2C IBS Offering
Regulatory Filings Classification · 98% confidence The document begins with 'RNS Number : 2719Q' and contains standard regulatory boilerplate language at the end referencing 'RNS, the news service of the London Stock Exchange' and the 'Financial Conduct Authority'. The content announces business updates: the launch of a D2C IBS offering, expansion of an agreement with Mount Sinai, and disclosure regarding a related party transaction. This is a typical structure for a regulatory news service announcement, which is a general disclosure mechanism for listed companies. Since it is not a full annual report (10-K), a specific financial supplement (XLSX), a formal earnings release (ER), or a proxy statement (DEF 14A/PSI), the most appropriate classification for a general, time-sensitive regulatory announcement on the RNS system is 'Regulatory Filings' (RNS), as it serves as the primary channel for such non-specific updates.
2023-02-17 English
New York Medicaid Health Plan Agreement
Earnings Release Classification · 99% confidence The document begins with 'RNS Number : 6495P' and contains standard regulatory boilerplate language at the end, including references to 'RNS, the news service of the London Stock Exchange' and the 'Financial Conduct Authority'. This strongly indicates a regulatory news service announcement. The content itself is an announcement of a new partnership and demonstration project ('Trellus IBD program to be offered through New York Medicaid Health Plan'). It is not a full financial report (like 10-K or IR), nor is it a transcript or presentation. Since it is a general, material business announcement distributed via the RNS system that doesn't fit a more specific category like Director's Dealing (DIRS), Dividend (DIV), or Capital Change (CAP), the most appropriate classification is the general regulatory filing/announcement category. 9M 2022
2023-02-13 English
Directorate Change
Board/Management Information Classification · 98% confidence The document is identified by the header 'RNS Number' and contains information released on '06 February 2023'. The core content announces a 'Directorate Change': the resignation of the Non-Executive Chairman and the appointment of a new Non-Executive Chairman. This directly corresponds to the definition of Board/Management Information (MANG). Although it is distributed via RNS, the specific content is about management changes, making MANG the most precise classification over the general RNS fallback.
2023-02-06 English
Trading Update & Related Party Transaction
Regulatory Filings Classification · 98% confidence The document is identified by the header 'RNS Number : 2343K' and contains a 'Trading Update & Related Party Transaction' dated December 20, 2022. It provides preliminary financial expectations for the year ending December 31, 2022, and discusses specific business contracts and related party disclosures under AIM Rules. This format—a brief update on trading and key operational/financial highlights released via the RNS system—is characteristic of an Earnings Release (ER) or a general regulatory announcement. Since it provides key financial expectations ('modest revenue and an EBITDA loss in line with expectations') but promises a 'more detailed trading update by early February 2023,' it fits the definition of an Earnings Release (ER) better than a comprehensive Interim Report (IR) or Annual Report (10-K). However, because it is explicitly distributed via RNS and contains miscellaneous regulatory disclosures (Related Party Transaction under AIM Rules) that might not be purely financial results, the most appropriate general category for a non-standard, timely regulatory announcement distributed via the LSE's news service is RNS, which serves as the fallback for specific announcements not covered elsewhere, especially when it mixes trading updates with regulatory compliance notes. Given the mix of trading update and AIM rule compliance, RNS is the safest classification, although ER is a strong secondary candidate.
2022-12-20 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is clearly identified by the header 'RNS Number : 7544J' and the closing statement mentions 'This information is provided by RNS, the news service of the London Stock Exchange.' The content details a 'TR-1: Standard form for notification of major holdings' regarding an acquisition of voting rights by an individual, James Robert Kight, crossing the 3% threshold. This type of mandatory disclosure regarding changes in significant share ownership aligns perfectly with the definition for Major Shareholding Notification (MRQ). Although it is distributed via RNS, the specific content dictates the MRQ classification over the general RNS fallback.
2022-12-14 English
Trellus IBD program launches on GI OnDEMAND
Regulatory Filings Classification · 99% confidence The document begins with 'RNS Number : 3299D' and is dated '19 October 2022'. It announces a partnership and the launch of a program ('Trellus IBD program launches on GI OnDEMAND'). The content is a press release format detailing business developments, partnerships, and product availability, rather than a formal financial report (like 10-K or IR) or a transcript. The presence of the RNS header and the nature of the announcement (a business update/partnership) strongly suggest it is a general regulatory announcement distributed via the London Stock Exchange's news service. Since it is not a specific financial report, management change, or dividend notice, the most appropriate classification is the general regulatory announcement category, RNS.
2022-10-19 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.